Gordon Findlay, an executive from Novo Nordisk, collapsed in the Oval Office on Thursday afternoon during President Trump’s announcement of a plan to lower the prices of weight-loss drugs, including Ozempic.
Findlay received immediate medical assistance and was helped to his feet. He is expected to recover fully.
Gordon Findlay of Novo Nordisk collapsed in the Oval Office Thursday afternoon as President Trump announced a plan to reduce the price of weight-loss drugs, including Ozempic.
The collapse occurred while the President unveiled initiatives aimed at making weight-loss medications more affordable. The plan specifically included drugs like Ozempic, a popular treatment for obesity.
"Gordon Findlay of Novo Nordisk collapsed in the Oval Office Thursday afternoon as President Trump announced a plan to reduce the price of weight-loss drugs, including Ozempic."
The unexpected collapse of a Novo Nordisk executive during a high-profile drug pricing announcement highlights the intense pressure surrounding healthcare reforms.